ReproCELL Incorporated

Tokyo Stock Exchange 4978.T

ReproCELL Incorporated Revenue for the year ending March 31, 2024: USD 16.03 M

ReproCELL Incorporated Revenue is USD 16.03 M for the year ending March 31, 2024, a -27.87% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • ReproCELL Incorporated Revenue for the year ending March 31, 2023 was USD 22.23 M, a 21.09% change year over year.
  • ReproCELL Incorporated Revenue for the year ending March 31, 2022 was USD 18.36 M, a 58.04% change year over year.
  • ReproCELL Incorporated Revenue for the year ending March 31, 2021 was USD 11.62 M, a 4.10% change year over year.
  • ReproCELL Incorporated Revenue for the year ending March 31, 2020 was USD 11.16 M, a 13.65% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
Tokyo Stock Exchange: 4978.T

ReproCELL Incorporated

CEO Dr. Shuji Yokoyama Ph.D.
IPO Date June 26, 2013
Location Japan
Headquarters MetLife Shin-Yokohama Building
Employees 96
Sector Health Care
Industries
Description

ReproCELL Incorporated operates as a stem cell research company in Japan. It offers stem cell reagents, including RNA reprogramming, small molecules, growth factors and cytokines, antibodies and staining kits, pluripotent stem cell culture media, cell substrates, cryopreservation media, dissociation solution, and transfection reagents; differentiated induced pluripotent stem cell (iPSC) and related reagents, feeder cells, and induced neurons; and 3D cell culture; and labware. The company also provides preclinical genomics, stem cell research, drug efficacy, safety, & ADME, human tissue samples, therapeutic pipeline, clinical laboratory services, clinical diagnostic services, and gmp ipsc master cell bank services. ReproCELL Incorporated was incorporated in 2003 and is based in Yokohama, Japan.

Similar companies

4571.T

NanoCarrier Co., Ltd.

USD 0.90

-4.23%

4564.T

OncoTherapy Science, Inc.

USD 0.15

4.16%

StockViz Staff

January 15, 2025

Any question? Send us an email